Development of a chemical probe against NUDT15
- 20 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Chemical Biology
- Vol. 16 (10), 1120-1128
- https://doi.org/10.1038/s41589-020-0592-z
Abstract
The NUDIX hydrolase NUDT15 was originally implicated in sanitizing oxidized nucleotides, but was later shown to hydrolyze the active thiopurine metabolites, 6-thio-(d)GTP, thereby dictating the clinical response of this standard-of-care treatment for leukemia and inflammatory diseases. Nonetheless, its physiological roles remain elusive. Here, we sought to develop small-molecule NUDT15 inhibitors to elucidate its biological functions and potentially to improve NUDT15-dependent chemotherapeutics. Lead compound TH1760 demonstrated low-nanomolar biochemical potency through direct and specific binding into the NUDT15 catalytic pocket and engaged cellular NUDT15 in the low-micromolar range. We also employed thiopurine potentiation as a proxy functional readout and demonstrated that TH1760 sensitized cells to 6-thioguanine through enhanced accumulation of 6-thio-(d)GTP in nucleic acids. A biochemically validated, inactive structural analog, TH7285, confirmed that increased thiopurine toxicity takes place via direct NUDT15 inhibition. In conclusion, TH1760 represents the first chemical probe for interrogating NUDT15 biology and potential therapeutic avenues.Keywords
This publication has 55 references indexed in Scilit:
- Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALLNature Medicine, 2013
- Multiple Nudix family proteins possess mRNA decapping activityRNA, 2013
- Effects of 6-Thioguanine and S6-Methylthioguanine on Transcription in Vitro and in Human CellsOnline Journal of Public Health Informatics, 2012
- Human MTH3 (NUDT18) Protein Hydrolyzes Oxidized Forms of Guanosine and Deoxyguanosine Diphosphates: COMPARISON WITH MTH1 AND MTH2Journal of Biological Chemistry, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Overview of theCCP4 suite and current developmentsActa crystallographica. Section D, Structural biology, 2011
- Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel diseaseWorld Journal of Gastroenterology, 2011
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa crystallographica. Section D, Structural biology, 2010
- Proliferating Cell Nuclear Antigen Is Protected from Degradation by Forming a Complex with MutT Homolog2Online Journal of Public Health Informatics, 2009
- Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non‐cirrhotic portal hypertension. RESULTS FROM MRC CML II TRIAL COMPARING BUSULPHAN WITH BUSULPHAN AND THIOGUANINEBritish Journal of Haematology, 1991